AR012250A1 - Derivados de 2-(iminometil)amino-fenilo, procedimientos para su preparacion, intermediarios utilizados en dichos procedimientos, medicamento y composicion farmaceutica que contienen a dichos derivados y uso de estos derivados para manufacturar un medicamento - Google Patents
Derivados de 2-(iminometil)amino-fenilo, procedimientos para su preparacion, intermediarios utilizados en dichos procedimientos, medicamento y composicion farmaceutica que contienen a dichos derivados y uso de estos derivados para manufacturar un medicamentoInfo
- Publication number
- AR012250A1 AR012250A1 ARP980102907A ARP980102907A AR012250A1 AR 012250 A1 AR012250 A1 AR 012250A1 AR P980102907 A ARP980102907 A AR P980102907A AR P980102907 A ARP980102907 A AR P980102907A AR 012250 A1 AR012250 A1 AR 012250A1
- Authority
- AR
- Argentina
- Prior art keywords
- thiazoline
- derivatives
- radical
- branched
- linear
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D521/00—Heterocyclic compounds containing unspecified hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Derivados de 2-(iminometil)amino-fenilo de la formula general (I): en la cual A es un átomo de hidrogeno o preferiblmente un aromático que tiene lasestructuras de formula (II), en donde R1 y R2 representan, independientemente, hidrogeno, halogeno ,CH, un radical alquilo C1-C6 lineal o ramificado, unradical alcoxi C1-C6 lineal o ramificado, R3 representa hidrogeno, un radical alquilo C1-C6 lineal o ramificado o un radical -COR4, representando R4 unradical alqulo C1-C6 de formula (III), o Brepresenta n radical alqulo C1-C6 lineal o ramificado, fenilo, piridinilo o un heterociclo con 5 miembros conteniendo 1 a 4 heteroátomos elegidos de O, S, N y más particularmente: tiofeno, furano, pirrol o tiazol, cuyos átomos de carbono está nopcionalmentesubstituídos por uno o más grupos elegidos de un radical alquilo C1-C6 lineal o ramificado; un radical alcoxi C1-C6 o halogeno; X representa -CO-N(R3)-X-, -NH-CO-X, -CH=, -CO- o un enlace representando X el resto -CH2)n-, siendo n unentero de 0 a 6, Y representa -Y-, -CO-NH-Y-, -Y-NH-CO, -CO-Y-, -N(R3)-Y,-Y-N(R3)-, -Y-CH2-N(R3)-CO-, -O-Y-,Y-O-, -Y-S-, -Y-O-Y, -Y-N(R3)-Y- o un enlace, Yrepresenta -(CH2)n siendo n un entero de 0 a 6; Het representa unheterociclo que contiene de1 a 5 heteroátomos elegidos de O, N, S, los cuales pueden estar sustituidos por uno o más sustituyentes X-OR3, X-NR3, X-S-R3,tal como por ejemplo: exetano, pirrol, pirrolidina, furano, tetrahidrofurano, tiofeno, tetrahidrotiofeno, sulfolano, imidazol, imidazolina, dihidroimidazol-2-ona, dihidroimidazol-2-tiona, oxazol, isoxazol, oxazolina, isoxazolina, oxaxolidina, oxazoolidinona, tiazol, tiazolina, tiazolidina, tiazolidinona,hidantoina, 1,2,4-tiazol, 1,3,4-oxadiazol, 1,1-dioxido-1,2,5-tiadiazolidina, 1,2,4-triazol-3-ona, tetrazol, tetrahidropirina, con la excepcion de los ..2
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9707701A FR2764889B1 (fr) | 1997-06-20 | 1997-06-20 | Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
AR012250A1 true AR012250A1 (es) | 2000-09-27 |
Family
ID=9508226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980102907A AR012250A1 (es) | 1997-06-20 | 1998-06-18 | Derivados de 2-(iminometil)amino-fenilo, procedimientos para su preparacion, intermediarios utilizados en dichos procedimientos, medicamento y composicion farmaceutica que contienen a dichos derivados y uso de estos derivados para manufacturar un medicamento |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP0991654B1 (es) |
JP (1) | JP2002507965A (es) |
KR (2) | KR100545946B1 (es) |
CN (1) | CN1195762C (es) |
AR (1) | AR012250A1 (es) |
AT (1) | ATE297935T1 (es) |
AU (1) | AU737964B2 (es) |
BR (1) | BR9810197B1 (es) |
CA (1) | CA2294809C (es) |
CZ (1) | CZ299237B6 (es) |
DE (1) | DE69830584T2 (es) |
DK (1) | DK0991654T3 (es) |
ES (1) | ES2244068T3 (es) |
FR (1) | FR2764889B1 (es) |
HK (1) | HK1030218A1 (es) |
HU (1) | HUP0002425A3 (es) |
IL (1) | IL133223A (es) |
MY (1) | MY123193A (es) |
NO (1) | NO315321B1 (es) |
NZ (1) | NZ501656A (es) |
PL (1) | PL191987B1 (es) |
PT (1) | PT991654E (es) |
RU (1) | RU2202543C2 (es) |
SK (1) | SK286911B6 (es) |
TR (1) | TR199903175T2 (es) |
TW (1) | TW422842B (es) |
UA (1) | UA70921C2 (es) |
WO (1) | WO1998058934A1 (es) |
ZA (1) | ZA985392B (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9801990D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl propionic acid derivatives and analogs |
US6355672B1 (en) * | 1998-08-07 | 2002-03-12 | Takeda Chemical Industries, Ltd. | Benzothiepin derivatives, process for the preparation of the same and uses thereof |
AR019190A1 (es) * | 1998-07-08 | 2001-12-26 | Sod Conseils Rech Applic | Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos |
FR2783519B1 (fr) * | 1998-09-23 | 2003-01-24 | Sod Conseils Rech Applic | Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
FR2798127A1 (fr) | 1999-09-03 | 2001-03-09 | Expansia Sa | Nouveau procede de preparation d'amidines derivees de l'acide 6-hydroxy-2,5,7,8-tetramethylchrommane-2-carboxy- lique |
FR2812546B1 (fr) * | 2000-08-01 | 2008-11-21 | Sod Conseils Rech Applic | Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments |
RU2380362C2 (ru) * | 1999-10-11 | 2010-01-27 | Сосьете Де Консей Де Решерш З | Производные пятичленных гетероциклов, способ их получения и их применение в качестве лекарственных средств |
TWI292316B (en) * | 1999-10-11 | 2008-01-11 | Sod Conseils Rech Applic | Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof |
FR2799461B1 (fr) * | 1999-10-11 | 2002-01-04 | Sod Conseils Rech Applic | Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments |
FR2801053B1 (fr) * | 1999-11-16 | 2004-06-25 | Sod Conseils Rech Applic | Nouveaux derives d'amidines, leur preparation et leur application a titre de medicaments |
SE9904677D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Ab | Novel compounds |
SE9904676D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Ab | Novel compounds |
GB0019006D0 (en) * | 2000-08-04 | 2000-09-20 | Astrazeneca Ab | Novel compounds |
WO2002020511A1 (en) * | 2000-09-05 | 2002-03-14 | Astrazeneca Ab | Amidine derivatives which are inhibitors of nitric oxide synthase |
TWI248438B (en) * | 2001-04-10 | 2006-02-01 | Sod Conseils Rech Applic | Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
EP1411930B1 (en) | 2001-06-08 | 2013-01-16 | Cytokine Pharmasciences, Inc. | Isoxazoline compounds having mif antagonist activity |
HU228783B1 (en) * | 2001-07-26 | 2013-05-28 | Greenearth Cleaning | Dry cleaning apparatus and method capable of utilizing a siloxane solvent |
US7141561B2 (en) | 2002-07-25 | 2006-11-28 | Sanofi-Aventis Deutschland Gmbh | Substituted diaryl heterocycles, process for their preparation and their use as medicaments |
DE10233817A1 (de) * | 2002-07-25 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
FR2842808B1 (fr) * | 2002-07-25 | 2004-09-10 | Sod Conseils Rech Applic | Nouveaux derives d'arylimidazoles, leur preparation et leurs applications therapeutiques |
BRPI0507818A (pt) * | 2004-03-26 | 2007-07-10 | Cytokine Pharmasciences Inc | composto e métodos de inibição |
WO2006022442A1 (ja) * | 2004-08-24 | 2006-03-02 | Santen Pharmaceutical Co., Ltd. | ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体 |
AU2006222556B2 (en) * | 2005-03-11 | 2011-09-29 | Armaron Bio Pty Ltd | Flavonoid compounds and uses thereof |
US8779157B2 (en) | 2009-09-04 | 2014-07-15 | Vanderbilt University | MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
WO2011058766A1 (en) * | 2009-11-16 | 2011-05-19 | Raqualia Pharma Inc. | Aryl carboxamide derivatives as ttx-s blockers |
CA2878567C (en) * | 2012-07-12 | 2021-02-23 | Khondrion Ip B.V. | Chromanyl derivatives for treating mitochondrial disease |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9127376D0 (en) * | 1991-12-24 | 1992-02-19 | Wellcome Found | Amidino derivatives |
DE69432019T2 (de) * | 1993-08-12 | 2003-11-27 | Astrazeneca Ab | Amidin-derivate mit stickstoffoxid-synthease-aktivität |
ATE182889T1 (de) * | 1994-05-07 | 1999-08-15 | Astra Ab | Bicyclische amidinderivate als no-synthetase inhibitoren |
-
1997
- 1997-06-20 FR FR9707701A patent/FR2764889B1/fr not_active Expired - Fee Related
-
1998
- 1998-06-10 TW TW087109245A patent/TW422842B/zh not_active IP Right Cessation
- 1998-06-15 DE DE69830584T patent/DE69830584T2/de not_active Expired - Lifetime
- 1998-06-15 CA CA002294809A patent/CA2294809C/fr not_active Expired - Fee Related
- 1998-06-15 TR TR1999/03175T patent/TR199903175T2/xx unknown
- 1998-06-15 CN CNB988073927A patent/CN1195762C/zh not_active Expired - Fee Related
- 1998-06-15 PL PL337499A patent/PL191987B1/pl not_active IP Right Cessation
- 1998-06-15 KR KR1019997012010A patent/KR100545946B1/ko not_active IP Right Cessation
- 1998-06-15 IL IL13322398A patent/IL133223A/en not_active IP Right Cessation
- 1998-06-15 ES ES98932205T patent/ES2244068T3/es not_active Expired - Lifetime
- 1998-06-15 AU AU82189/98A patent/AU737964B2/en not_active Ceased
- 1998-06-15 BR BRPI9810197-8A patent/BR9810197B1/pt not_active IP Right Cessation
- 1998-06-15 DK DK98932205T patent/DK0991654T3/da active
- 1998-06-15 PT PT98932205T patent/PT991654E/pt unknown
- 1998-06-15 CZ CZ0459799A patent/CZ299237B6/cs not_active IP Right Cessation
- 1998-06-15 AT AT98932205T patent/ATE297935T1/de active
- 1998-06-15 EP EP98932205A patent/EP0991654B1/fr not_active Expired - Lifetime
- 1998-06-15 UA UA99126913A patent/UA70921C2/uk unknown
- 1998-06-15 HU HU0002425A patent/HUP0002425A3/hu unknown
- 1998-06-15 WO PCT/FR1998/001250 patent/WO1998058934A1/fr active IP Right Grant
- 1998-06-15 NZ NZ501656A patent/NZ501656A/en not_active IP Right Cessation
- 1998-06-15 KR KR1020057016237A patent/KR100618478B1/ko not_active IP Right Cessation
- 1998-06-15 RU RU2000101328/04A patent/RU2202543C2/ru not_active IP Right Cessation
- 1998-06-15 SK SK1796-99A patent/SK286911B6/sk not_active IP Right Cessation
- 1998-06-15 JP JP50387199A patent/JP2002507965A/ja active Pending
- 1998-06-18 AR ARP980102907A patent/AR012250A1/es active IP Right Grant
- 1998-06-19 ZA ZA985392A patent/ZA985392B/xx unknown
- 1998-06-19 MY MYPI98002787A patent/MY123193A/en unknown
-
1999
- 1999-12-15 NO NO19996208A patent/NO315321B1/no not_active IP Right Cessation
-
2001
- 2001-02-21 HK HK01101230A patent/HK1030218A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR012250A1 (es) | Derivados de 2-(iminometil)amino-fenilo, procedimientos para su preparacion, intermediarios utilizados en dichos procedimientos, medicamento y composicion farmaceutica que contienen a dichos derivados y uso de estos derivados para manufacturar un medicamento | |
PT684945E (pt) | Inibidores de acat a base de alquilamida substituida com pirazol ou isoxazol | |
PE20030200A1 (es) | Bencimidazol como inhibidores de las map quinasas | |
BRPI0213243B8 (pt) | composto heterocíclico aromático contendo um anel oxazol, tiazol ou imidazol, ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica | |
CY1110263T1 (el) | Νεες ενωσεις ισοξαζολης και θειαζολης και η χρηση τους ως φαρμακα | |
KR890005095A (ko) | 신규 화합물들 | |
PE20020100A1 (es) | DERIVADOS DE 2-SULFONIL AMINO-1,3-TIAZOL COMO INHIBIDORES DE 11-ß-HIDROXI ESTEROIDE DESHIDROGENASA TIPO 1 (11ßHSD1) | |
HRP20010468B1 (en) | Azabicycloalkanes as ccr5 modulators | |
CA2057913A1 (en) | N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present | |
HUP0103469A2 (hu) | Szubsztituált oxazol- és tiazolszármazékok hPPAR gamma és hPPAR alfa aktivátor hatással és a vegyületeket tartalmazó gyógyszerkészítmények | |
DK444581A (da) | Beta-lactam-forbindelser og farmaceutisk taalelige salte deraf fremgangsmaade til deres fremstilling og deres anvendelse | |
KR890017237A (ko) | 벤즈아마이드 프로테아제 억제제 | |
AR012102A1 (es) | Derivados de 2-(iminometil)amino-fenilo, su preparacion, uso de los mismos para la fabricacion de medicamentos y composiciones farmaceuticas que los contienen. | |
NZ318515A (en) | Cyclodepsipeptide PF1022 derivatives and compositions thereof | |
NZ215175A (en) | Barbituric acid derivatives and anthelmintic compositions | |
IE880331L (en) | Substituted 2,6-substituted pyridine compounds | |
RU2008104422A (ru) | Активатор рецептора дельта, активируемого пролифератором | |
KR910000684A (ko) | 소염제 페나메이트 1,3,4-티아디아졸 및 1,3,4-옥사디아졸 | |
NO171166C (no) | Analogifremgangsmaate for fremstilling av beta-d-fenyltioxylosider | |
RU2007135745A (ru) | АКТИВАТОР δ- РЕЦЕПТОРА, АКТИВИРУЕМОГО ПРОЛИФЕРАТОРОМ ПЕРОКСИСОМЫ | |
PE20020600A1 (es) | Heteroaromatos como inhibidores de la 2,3-oxidoescualeno-lanosterol ciclasa | |
KR890002134A (ko) | 1,2-벤즈 이속 사졸 및 1,2-벤즈 이소 티아졸 유도체 | |
KR910000141A (ko) | 이소옥사졸린-3-온 유도체의 항울제로서의 용도 | |
AR018985A1 (es) | Uso de una composicion farmaceutica para prevenir infecciones por vih y otras infecciones retrovirales | |
KR970032864A (ko) | 골다공증 치료제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |